Micropharmacology of Monoclonal Antibodies in Solid Tumors: Direct Experimental Evidence for a Binding Site Barrier (original) (raw)

Theoretic Criteria for Antibody Penetration into Solid Tumors and Micrometastases

Greg Thurber

Journal of Nuclear Medicine, 2007

View PDFchevron_right

Predicted and observed effects of antibody affinity and antigen density on monoclonal antibody uptake in solid tumors

T. Shockley

Cancer research, 1992

View PDFchevron_right

Comparison of in vitro cell binding characteristics of four monoclonal antibodies and their individual tumor localization properties in mice

Geoffrey Pietersz

Cancer research, 1990

View PDFchevron_right

A simple in vitro method of screening panels of monoclonal antibodies for tumor binding

Frank Virzi

Journal of Immunological Methods, 1985

View PDFchevron_right

Factors determining antibody distribution in tumors

Greg Thurber

Trends in Pharmacological Sciences, 2008

View PDFchevron_right

Localization by hand-held gamma probe of tumor labeled with antibody “cocktail”

S. Tuttle

Journal of Surgical Research, 1989

View PDFchevron_right

The effect of antibody protein dose on the uniformity of tumor distribution of radioantibodies: An autoradiographic study

Otto Boerman

Cancer Immunology Immunotherapy, 1991

View PDFchevron_right

Kinetics of anti-carcinoembryonic antigen antibody internalization: effects of affinity, bivalency, and stability

Greg Thurber

Cancer Immunology, Immunotherapy, 2008

View PDFchevron_right

Monoclonal antibody internalization by tumor cells: an experimental model for potential radioimmunotherapy applications

Giuliano Mariani

International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1989

View PDFchevron_right

Influence of affinity and antigen density on antibody localization in a modifiable tumor targeting model

lionel zuckier

Cancer research, 2000

View PDFchevron_right

Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance

Greg Thurber

Advanced Drug Delivery Reviews, 2008

View PDFchevron_right

Kennel, S. J. Effects of target antigen competition on distribution of monoclonal antibody to solid tumors. Cancer Res

Stephen Kennel

Cancer Research

View PDFchevron_right

Effects of Target Antigen Competition on Distribution of Monoclonal Antibody to Solid Tumors

Stephen Kennel

Cancer Research, 1992

View PDFchevron_right

The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors

Otto Boerman

International Journal of Cancer, 1992

View PDFchevron_right

Attempted targeting of a monoclonal antibody in a human tumour xenograft system

Hilmar Warenius

European journal of cancer & clinical oncology, 1981

View PDFchevron_right

Quantity and accessibility for specific targeting of receptors in tumours

Gary B Braun

Scientific reports, 2014

View PDFchevron_right

Monoclonal antibodies for imaging and therapy of cancer. 817

J. Kosterink

View PDFchevron_right

A quantitative analysis of tumor specific monoclonal antibody uptake by human melanoma xenografts: effects of antibody immunological properties and tumor antigen expression levels

T. Shockley

Cancer research, 1992

View PDFchevron_right

Localization of biotinylated monoclonal antibody in nude mice bearing subcutaneous and intraperitoneal human tumour xenografts

Shahid Pervez

International Journal of Cancer, 1988

View PDFchevron_right

Role of Monoclonal Antibodies in the Therapy of Solid Tumours

Geoffrey Pietersz

ANZ Journal of Surgery, 1988

View PDFchevron_right

Effect of Small-Molecule-Binding Affinity on Tumor Uptake In Vivo: A Systematic Study Using a Pretargeted Bispecific Antibody

Kelly Orcutt

Molecular Cancer Therapeutics, 2012

View PDFchevron_right

The Interaction between Cell-Surface Antigens and Antibodies Bound to Monodisperse Polymer Particles in Normal and Malignant Cells

Kjell Nustad

Scandinavian Journal of Immunology, 1986

View PDFchevron_right

Influence of Affinity and Antigen Internalization on the Uptake and Penetration of Anti-HER2 Antibodies in Solid Tumors

Andres J P Klein-Szanto

Cancer Research, 2011

View PDFchevron_right

Three-Step Monoclonal Antibody Tumor Targeting in Carcinoembryonic Antigen positive Patients

Claudio Rossetti

1991

View PDFchevron_right

Antibody or Antibody Fragments: Implications for Molecular Imaging and Targeted Therapy of Solid Tumors

Paul M. P. Bergen Henegouwen

Frontiers in immunology, 2017

View PDFchevron_right

Impact of charge patches on tumor disposition and biodistribution of therapeutic antibodies

Sasa Miladinovic

AAPS Open, 2022

View PDFchevron_right

Modeling analysis of the global and microscopic distribution of immunoglobulin G, F(ab')2, and Fab in tumors

Jack Fletcher

Cancer research, 1989

View PDFchevron_right

Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor

Otto Boerman

Cancer Immunology Immunotherapy, 1992

View PDFchevron_right

High Affinity Restricts the Localization and Tumor Penetration of Single-Chain Fv Antibody Molecules1

Grégory ADAMS

2001

View PDFchevron_right

Dynamics of antibody transport and internalization

Eva-Bettina Brocker

International Journal of Cancer, 1988

View PDFchevron_right

Influence of Affinity and Antigen Density on Antibody Localization in a Modifiable Tumor Targeting Model1

lionel zuckier

2000

View PDFchevron_right

The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas

Markwin Velders

British journal of cancer, 1998

View PDFchevron_right

Dose dependent pharmacokinetics, tissue distribution, and anti-tumor efficacy of a humanized monoclonal antibody against DLL4 in mice

Ben-Quan Shen

mAbs, 2014

View PDFchevron_right

Quantitating Antibody Uptake In Vivo: Conditional Dependence on Antigen Expression Levels

Greg Thurber

Molecular Imaging and Biology, 2011

View PDFchevron_right

Complementation of intracavitary and intravenous administration of a monoclonal antibody (B72. 3) in patients with carcinoma

Jose Esteban S.

1987

View PDFchevron_right